SHEN Zan  

  • Chief Physician, Doctoral Supervisor
  • Department: Oncology
  • Research Area: Oncology
  • Research Interests: Research on drug resistance  and metastasis mechanism of tumor
  • Contact: sshenzzan@vip.sina.com
  • Director of Department of Oncology, Shanghai Sixth People's Hospital, 2008
  • PhD from Hong Kong University, 2008
  • MPH from Fudan University, 2002
  • Director of Department of Oncology, Shanghai Sixth People's Hospital
  • Member of Cancer Society and Group leader of Supportive Oncology of Chinese Medical Association
  • Chairman of  Knotty Tumor Committee of China Medical Education Association
  • Managing vice director Of Industry-University-Research medical treatment Collaboration of China Soong Ching Ling Foundation
  • Vice Chairman of Cancer Society of  Shanghai Medical Society 
  • Member of the Standing Committee and Secretary of Cancer Society of Shanghai Medical Doctor Association
  • Chairman of Cardio-Oncology Committee of Shanghai Anticancer Association
  1. Xiaojing.Yang,Hanru.Ren,Yi.Xu,Xue.Peng,Wenxi.Yu,Zan.Shen#Combination of radiotherapy and targeted therapy for HER2-positive breast cancer brain metastases.European journal of medical research.2023,10.1186/s40001-022-00894-7
  2. S Zheng,C Zhou,G Qian,Y Zhou,Z Shen#,Mutational landscape of Chinese osteosarcoma patients.Journal of Clinical Oncology,2022,10.1200/JCO.2021.39.15
  3. Wang, Jiahui,Hong, Jinsheng,Shen, Zan#A deficient MIF-CD74 signaling pathway may play an important role in immunotherapy-induced hyper-progressive disease,Cell Biology and Toxicology,2021,10.1007/s10565-021-09672-3
  4. Zhenni Sun,Xiaomei Xu,Zan Shen#NHE1 Mediates 5-Fu Resistance in Gastric Cancer via STAT3 Signaling Pathway.OncoTargets and Therapy.2021,10.2147/OTT.S256274
  5. Shuier Zheng,Chenliang Zhou,Yonggang Wang,Hongtao Li,Zan Shen#TRIM6 promotes colorectal cancer cells proliferation and response to thiostrepton by TIS21/FoxM1.Journal of Experimental & Clinical Cancer Research.2020.10.1186/s13046-022-02434-x